Pleuromutilin Thioester Derivative Combating Drug-Resistant Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The rise of drug-resistant bacteria poses a significant clinical challenge due to bacterial adaptability and the overuse of antibiotics, necessitating the development of effective antibacterial agents.
Innovation Solution
Modification of pleuromutilin through the structure of 2-[(diphenylmethyl)thio]acetic acid to create pleuromutilin 2-[(diphenylmethyl)thio]acetic acid ester, which involves reacting pleuromutilin with 2-[(diphenylmethyl)thio]acetic acid in specific conditions to produce a compound with enhanced antibacterial activity against multi-drug-resistant bacteria.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then treatment is effective against sensitive bacteria, but bacteria develop drug resistance through genetic mutation and overuse
Solution Approach 1:
The patent modifies the chemical structure of pleuromutilin by introducing a 2-[(diphenylmethyl)thio]acetic acid ester group at the C2 position, changing the molecular parameters to create a derivative with enhanced activity against drug-resistant bacteria while maintaining the core tricyclic diterpenoid skeleton
Solution Approach 2:
The invention creates a hybrid compound combining the pleuromutilin core structure with the 2-[(diphenylmethyl)thio]acetic acid side chain, forming a composite molecular structure that exhibits synergistic antibacterial properties against multi-drug-resistant strains
2Reliability
If pleuromutilin is modified to enhance antibacterial activity, then effectiveness against drug-resistant bacteria improves, but synthesis complexity increases
Solution Approach 1:
The synthesis is divided into distinct stages: activation of 2-[(diphenylmethyl)thio]acetic acid with thionyl chloride to form the acid chloride, followed by separate esterification with pleuromutilin, allowing each step to be optimized and controlled independently
Solution Approach 2:
The patent uses 2-[(diphenylmethyl)thio]acetic acid chloride as an intermediate compound to facilitate the modification of pleuromutilin, enabling controlled introduction of the functional group without direct complex coupling
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting pleuromutilin 2-[(diphenylmethyl)thio]acetic acid ester demonstrates strong antibacterial activity, particularly against multi-resistant Staphylococcus aureus strains, offering a promising candidate for treating infectious diseases caused by drug-resistant bacteria.
Implementation Method 1
The resulting pleuromutilin 2-[(diphenylmethyl)thio]acetic acid ester demonstrates strong antibacterial activity, particularly against multi-resistant Staphylococcus aureus strains
Data Source
AI summary
A compound with anti-drug resistant bacteria activity having the formula (I):(I) is disclosed. The methods of preparing the compound of formula (I) are also disclosed.